603108 润达医疗
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)2.1206.69111.36511.40811.070
总资产报酬率 ROA (%)0.6341.8963.1493.4273.436
投入资产回报率 ROIC (%)0.7992.4384.0574.3154.257

边际利润分析
销售毛利率 (%)27.10026.58327.99026.99827.043
营业利润率 (%)5.6167.0717.7798.7799.107
息税前利润/营业总收入 (%)9.56610.62910.89412.10012.412
净利润/营业总收入 (%)3.6824.8396.2426.7527.127

收益指标分析
经营活动净收益/利润总额(%)99.55375.566103.84189.67385.806
价值变动净收益/利润总额(%)29.73835.39016.72017.66621.431
营业外收支净额/利润总额(%)1.9441.3350.4000.341-1.247

偿债能力分析
流动比率 (X)1.2201.2481.1541.2041.123
速动比率 (X)1.0471.0650.9640.9610.915
资产负债率 (%)61.97361.93465.49463.45059.905
带息债务/全部投入资本 (%)60.93660.04463.45261.096--
股东权益/带息债务 (%)61.54363.12155.09559.83665.691
股东权益/负债合计 (%)48.22648.29340.89245.41652.546
利息保障倍数 (X)2.4923.0703.5333.6763.632

营运能力分析
应收账款周转天数 (天)240.561225.516165.206136.5200.000
存货周转天数 (天)82.00080.21774.27673.9180.000